Targeted use of heparin, heparinoids, or low-molecular-weight heparin to improve outcome after acute ischaemic stroke: an individual patient data meta-analysis of randomised controlled trials

BACKGROUND: Many international guidelines on the prevention of venous thromboembolism recommend targeting heparin treatment at patients with stroke who have a high risk of venous thrombotic events or a low risk of haemorrhagic events. We sought to identify reliable methods to target anticoagulant tr...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Whiteley, William N, Adams, Harold P, Bath, Philip MW, Berge, Eivind, Sandset, Per Morten, Dennis, Martin, Murray, Gordon D, Wong, Ka-Sing Lawrence, Sandercock, Peter AG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Lancet Pub. Group 2013
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3671273/
https://ncbi.nlm.nih.gov/pubmed/23642343
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(13)70079-6
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak